Skip to main content

Day: August 4, 2021

Sky Century Investment, Inc. Announces Its Plans to Expand Its CBD Products Assortment

Las Vegas, NV, Aug. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sky Century Investment, Inc. (OTC Markets: SKYI), a Nevada registered company, committed to selling the highest quality CBD products using only pharmaceutical grade ingredients to provide the best product on the market for its customers, publicly announces its plans to expand its CBD products assortment. Sky Century Investment, Inc. is pleased to announce that they intend to focus on expanding their product line with CBD content. This decision is made due to the fact that the providing of a wide range of CBD products will be beneficial for both the Company and its customers. CBD (or Cannabidiol), is one of more than 100 chemicals called cannabinoids that have been identified in the cannabis plant. CBD has been thoroughly studied for its healing properties...

Continue reading

SJI Reports Second Quarter 2021 Results Reaffirms Guidance

Folsom, NJ, Aug. 04, 2021 (GLOBE NEWSWIRE) —Investor Contact:Daniel Fidell609-561-9000 x7027dfidell@sjindustries.com Media Contact:Dominick DiRocco609-561-9000 x4262ddirocco@sjindustries.comSJI Reports Second Quarter 2021 ResultsReaffirms Guidance FOLSOM, NJ (August 4, 2021) – SJI (NYSE: SJI) today reported operating results for the second quarter and year-to-date (YTD) periods ended June 30, 2021. Highlights include:Q2 2021 GAAP earnings $(0.87) per diluted share compared to $(0.03) per diluted share in 2020; Economic Earnings* $0.02 per diluted share compared to $(0.01) per diluted share in 2020 YTD 2021 GAAP earnings $0.30 per diluted share compared to $1.06 per diluted share in 2020; Economic Earnings $1.22 per diluted share compared to $1.14 per diluted share in 2020 Q2 2021/YTD GAAP...

Continue reading

Media Central Corporation Appoints Greg Messinger to Advisory Board

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) — Media Central Corporation Inc. (CSE: FLYY, FSE: 3AT) (“Media Central” or the “Company”), a publicly held holding company of media assets that trades on the Canadian Securities Exchange, today announced that it has appointed Greg Messinger to the company’s Advisory Board. Mr. Messinger has a 15-year track record of leading significant growth initiatives at media and technology organizations across three continents. He has a proven history of creating enterprise value through product development and revenue growth leadership. In 2010, Mr. Messinger co-founded a digital services agency and grew the business from $0 to over $100MM in annual revenue over the course of 5 years. After successfully exiting that role, he went on to develop a senior management consulting practice....

Continue reading

Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates

Announced positive results of the Saturn-1 pivotal trial evaluating TP-03 for the treatment of Demodex blepharitis; results presented at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) conference Initiated Saturn-2, second pivotal Phase 3 trial evaluating the safety and efficacy of TP-03 for the treatment of Demodex blepharitis; Saturn-2 trial design similar to Saturn-1, topline data expected in Q1 2022 Initiated the Phase 1 Callisto trial evaluating TP-05, a novel, oral, non-vaccine therapeutic, for the prevention of Lyme disease Cash and equivalents of $177 million, plus TP-03 license receivables of $20 million as of June 30, 2021 IRVINE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet...

Continue reading

SJI to Host Second Quarter 2021 Earnings Conference Call

Folsom, NJ, Aug. 04, 2021 (GLOBE NEWSWIRE) —                                                                                              Investor Contact: Dan Fidell(609) 561-9000 ext. 7027dfidell@sjindustries.com Media Contact: Dominick DiRocco(732) 239-4462ddirocco@sjindustries.com FOR IMMEDIATE RELEASE SJI to Host Second Quarter 2021 Earnings Conference Call FOLSOM, NJ, July 14, 2021 – SJI (NYSE: SJI) President and Chief Executive Officer, Michael J. Renna, along with key members of the company’s Senior Management team, will host an open conference call and webcast to review the company’s second quarter 2021 financial results on Thursday, August 5, 2021 at 11:00 A.M. ET. SJI will release these results on Wednesday, August 4, 2021, following the market close. To listen to the conference call, please dial either the toll-free...

Continue reading

HighPeak Energy, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call

FORT WORTH, Texas, Aug. 04, 2021 (GLOBE NEWSWIRE) — HighPeak Energy, Inc. (NASDAQ: HPK) (“HighPeak Energy”), today announced that it plans to release second quarter 2021 financial results after the close of trading on Monday, August 9, 2021. HighPeak Energy will host a conference call and webcast on Tuesday, August 10, 2021 at 10:00 a.m. Central Time for investors and analysts to discuss its 2021 second quarter financial results and operational highlights. Conference call participants may call (833) 362-0226 (United States/Canada) or (914) 987-7683 (International) and enter confirmation code 1119639. A live broadcast of the earnings conference call will also be available on the HighPeak Energy’s website at www.highpeakenergy.com under the “Investors” section of the website. A replay will be available on the website following the...

Continue reading

Mueller Water Products Reports 2021 Third Quarter Results

Achieved Record Net Sales of $310.5 million, a 35.9 percent Increase Reported Net Income per Diluted Share of $0.09 and Adjusted Net Income per Diluted Share of $0.18 Increased adjusted EBITDA 42.9 percent to $62.6 million ATLANTA, Aug. 04, 2021 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) announced today that for its fiscal 2021 third quarter ended June 30, 2021, net sales were $310.5 million and net income was $14.4 million. During the quarter, the Company:Increased net sales 35.9 percent to $310.5 million as compared with $228.5 million in the prior year quarter. Generated operating income of $42.7 million as compared with $20.0 million in the prior year quarter. Increased adjusted operating income 62.9 percent to $46.6 million as compared with $28.6 million in the prior year quarter. Achieved net income of...

Continue reading

Healthcare Realty Trust Reports Results for the Second Quarter

NASHVILLE, Tenn., Aug. 04, 2021 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2021. The Company reported net income of $23.1 million, or $0.16 per diluted common share, for the quarter ended June 30, 2021. Normalized FFO for the three months ended June 30, 2021 totaled $60.8 million, or $0.43 per diluted common share. Salient quarterly highlights include:Normalized FFO per share totaled $0.43, an increase from $0.42 in the second quarter of 2020. Same store cash NOI for the second quarter increased 2.9% over the second quarter of 2020. For the trailing twelve months ended June 30, 2021, same store cash NOI grew 2.3%. Predictive growth measures in the same store portfolio include:Average in-place rent increases of 2.87% Future annual contractual...

Continue reading

Global Indemnity Group, LLC Reports Second Quarter 2021 Results

BALA CYNWYD, Pa., Aug. 04, 2021 (GLOBE NEWSWIRE) — Global Indemnity Group, LLC (NASDAQ:GBLI) (the “Company”) today reported net income available to shareholders of $11.7 million for the six months ended June 30, 2021 compared to net loss available to shareholders of ($7.0) million for the corresponding period in 2020. Adjusted operating income was $4.0 million for the six months ended June 30, 2021 compared to $17.5 million for the corresponding period in 2020, which period included a $19.9 million release of prior year reserves as compared to a $2.1 million increase in prior year reserves in the current period. Gross Written Premiums increased 5.8% to $338.8 million for the six months ended June 30, 2021, including 9.4% growth in the Company’s core Commercial Specialty business segment. Gross Written Premiums of $338.8 million...

Continue reading

Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Second Quarter Ended June 30, 2021

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) — Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the second quarter ended June 30, 2021. Please note that all amounts referred to in this press release are in Euros unless otherwise stated. The following press release should be read in conjunction with the Company’s Unaudited Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2021 and the accompanying notes, our Management Discussion and Analysis for the three and six months ended June 30, 2021 and the Annual Consolidated Financial Statements of Constellation Software Netherlands Holding Cooperatief U.A. (the “Topicus Coop” or “CSNH”) for the year ended December 31,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.